Todd C. Brady - 23 Jun 2022 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role: President and CEO, Director
Signature: /s/ Todd C. Brady
Issuer symbol: ALDX
Transactions as of: 23 Jun 2022
Transactions value $: $59,546
Form type: 4
Filing time: 27 Jun 2022, 06:41:07 UTC
Previous filing: 22 Jun 2022
Next filing: 19 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALDX	Common Stock	Purchase	$59.5K	+17.7K	+1.48%	$3.36	1.22M	23 Jun 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.3591 to $3.3693, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.3591 to $3.3693, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.